Highlights
- Third quarter Revenue was USD 31,944 thousand against USD 34,993 thousand a year earlier.
- Net loss was USD 7,173 thousand against USD 9,512 thousand a year earlier.
- Cash and cash equivalents were USD 15,182 thousand at September 30.
- ATM proceeds prepaid USD 0.7 million of term loans, plus USD 1.7 million in October.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) shares were trading near their all-time low at USD 0.60 on November 6, 2026, down 58.33% on the day. The body contouring provider reported third quarter revenue of USD 31,944 thousand and a net loss of USD 7,173 thousand.
The company operates 31 centers across 20 states and Canada as of November 6, 2026 and delivers its proprietary AirSculpt procedures, which remove unwanted fat and tighten skin in a minimally invasive procedure.
Where the Numbers Stand
Revenue was USD 31,944 thousand against USD 34,993 thousand in the third quarter of 2025. For the nine months ended September 30, 2026, revenue was USD 114,233 thousand against USD 118,376 thousand, a decrease of USD 4.1 million, or 3.5%.
Total operating expenses were USD 36,083 thousand against USD 44,743 thousand. The loss from operations narrowed to USD 4,139 thousand from USD 9,750 thousand. The net loss was USD 7,173 thousand against USD 9,512 thousand, and the nine-month net loss was USD 10,682 thousand against USD 12,950 thousand.
Volume and Center Count
The filing reports that nine-month revenue included a 2.1% decrease in same center Volume and a 0.2% decrease in average selling price on a same-center basis. The prior year period also included the London clinic, which was closed as of December 31, 2025.
Depreciation and amortization was approximately USD 2.9 million in the quarter against USD 3.2 million. The filing notes a net reduction of one clinic location and one office location between the periods.
Debt and Interest
Interest expense, net, was USD 1.2 million in the quarter against USD 1.4 million, and USD 3.5 million for the nine months against USD 4.6 million. The filing cites a USD 1.3 million decrease in interest on outstanding Debt from principal prepayments for the nine-month change.
As of September 30, 2026, the company had prepaid USD 0.7 million of its term loans from net proceeds of at-the-market Equity issuances. On October 20, 2026, it made an additional prepayment of USD 1.7 million from ATM net proceeds.
Operating Results in Context
The loss from operations for the nine months was USD 5,970 thousand against USD 10,553 thousand, and total operating expenses were USD 120,203 thousand against USD 128,929 thousand. The quarterly operating loss of USD 4,139 thousand compares with USD 9,750 thousand in the third quarter of 2025.
The net loss for the quarter was larger than the operating loss. Interest expense, net, was USD 1.2 million in the quarter.
Liquidity
The company lists cash on hand, proceeds from sales of common stock under its at-the-market program and up to USD 5.0 million in revolving loans as principal sources of liquidity. The revolving Facility is subject to minimum Liquidity draw requirements.
Cash and cash equivalents were USD 15,182 thousand against USD 8,449 thousand at December 31, 2025. Net cash provided by Operating Activities was USD 558 thousand for the nine months against USD 5,627 thousand.
Balance Sheet
Total Assets were USD 187,776 thousand against USD 187,304 thousand at year end. Total liabilities were USD 81,840 thousand against USD 99,592 thousand, and total stockholders' equity was USD 105,936 thousand against USD 87,712 thousand. The accumulated Deficit was USD 51,253 thousand.
The company had 73,925,997 shares of common stock outstanding as of November 6, 2026.
Share Count and Equity
The company filed a Form S-3 registration statement in March 2025 covering the offer and sale of securities, and it sells common stock under its at-the-market program. Shares outstanding stood at 73,925,997 as of November 6, 2026. Stockholders' equity rose to USD 105,936 thousand from USD 87,712 thousand over the nine months.






Please wait processing your request...